Objective: To review and compare side effects of hepatitis C treatment with pegylated interferon and ribavirin at the CRIE of the Hospital Mário Covas (Santo André), São Paulo, Brazil, from February 23 to May 5, 2011.
Methods: Cross-sectional study through questionnaire, with a non-probability sample comprised of 340 patients that had received at least one dose of the medication.
Results: Side effects presented were fatigue (82.